This 2.5-day conference will convene leading researchers, clinicians, pediatric cancer advocates, and industry and governmental stakeholders from around the world dedicated to improving the understanding and treatment of pediatric cancers. These unique cancers continue to be challenging to treat despite improved survival rates. Advances in biomedicine have illustrated that the underlying etiology of pediatric cancers may be far different than their adult counterparts, emphasizing the need for more precise therapeutic options.
Craig B. Thompson, MD
Memorial Sloan Kettering Cancer Center
AGENDA TOPICS INCLUDE
- Epigenetics for enhancing therapeutic discovery and diagnosis
- Immunotherapy as an emerging pediatric cancer therapy
- Mechanisms of tumor metastasis and dissemination
- Improving pediatric cancer clinical trials and access
- Metabolic reprogramming in pediatric tumor development.
You are invited to the heart of vibrant New York City for this timely and exciting international conference. For complete information, registration, accommodations, etc. visit www.nyas.org/Sohn2016